ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinomaKen Tanaka(University of Tsukuba), Hiroyuki Nishiyama(Kyoto University)Oncology ReportsNovember 26, 202110.3892/or.2021.8234Cited by 42SaveCiteExport RISWatch citationsRelated PapersSensitizing Effect of Galectin-7 in Urothelial Cancer to Cisplatin through the Accumulation of Intracellular Reactive Oxygen Species|Cancer Research|2007|53